Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Agrawal

Showing results (311-320 of 313) with videos related to

Pageof 32
Sort By:
You have reached the last page of results.This site can display upto 313 results.
Journal of Hospital Medicine|January 20, 2024
Wall-mounted folding chairs to promote resident physician sitting at the hospital bedsideBlair P Golden, Sean Tackett, Kimiyoshi Kobayashi, et al.
JAMA|September 9, 2000
Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety StudyF E Silverstein, G Faich, J L Goldstein, et al.
Leukemia|January 17, 2017
Incidence and prognostic impact of ASXL2 mutations in adult acute myeloid leukemia patients with t(8;21)(q22;q22): a study of the German-Austrian AML Study GroupN Jahn, M Agrawal, L Bullinger, et al.
Pageof 32

Showing results (311-320 of 313) with videos related to

Sort By:
Pageof 32
You have reached the last page of results.This site can display upto 313 results.
Journal of Hospital Medicine|January 20, 2024
Wall-mounted folding chairs to promote resident physician sitting at the hospital bedsideBlair P Golden, Sean Tackett, Kimiyoshi Kobayashi, et al.
JAMA|September 9, 2000
Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety StudyF E Silverstein, G Faich, J L Goldstein, et al.
Leukemia|January 17, 2017
Incidence and prognostic impact of ASXL2 mutations in adult acute myeloid leukemia patients with t(8;21)(q22;q22): a study of the German-Austrian AML Study GroupN Jahn, M Agrawal, L Bullinger, et al.
Pageof 32